Cargando…
MYC and BCL2 overexpression is associated with a higher class of Memorial Sloan-Kettering Cancer Center prognostic model and poor clinical outcome in primary diffuse large B-cell lymphoma of the central nervous system
BACKGROUND: Primary diffuse large B-cell lymphoma of the central nervous system (PCNS-DLBCL) is a distinct clinicopathological entity with a poor prognosis. Concurrent MYC and BCL2 overexpression predicts inferior prognosis in systemic DLBCLs. However, the prognostic significance of MYC and BCL2 in...
Autores principales: | Kim, Sehui, Nam, Soo Jeong, Kwon, Dohee, Kim, Hannah, Lee, Eunyoung, Kim, Tae Min, Heo, Dae Seog, Park, Sung Hye, Kim, Chul Woo, Jeon, Yoon Kyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4903010/ https://www.ncbi.nlm.nih.gov/pubmed/27286976 http://dx.doi.org/10.1186/s12885-016-2397-8 |
Ejemplares similares
-
Caregivers Clinic at Memorial Sloan Kettering Cancer Center
por: Applebaum, Allison
Publicado: (2021) -
Surgical management of hilar cholangiocarcinoma at Memorial Sloan Kettering Cancer Center
por: Lidsky, Michael E., et al.
Publicado: (2018) -
The Memorial Sloan Kettering Prognostic Score: Correlation with survival in patients with advanced gastric cancer
por: Wan, Mingyu, et al.
Publicado: (2023) -
Integrative Cancer Care in a US Academic Cancer Centre: The Memorial Sloan–Kettering Experience
por: Deng, G.
Publicado: (2008) -
Memorial Sloan-Kettering Cancer Center: Two Decades of Experience with Ductal Carcinoma In Situ of the Breast
por: Choi, Daniel Xavier, et al.
Publicado: (2012)